TGA Response: Prohibited Ingredients in E-Cigarettes

Regulations by 2FIRSTS.ai
Jun.21.2023
TGA Response: Prohibited Ingredients in E-Cigarettes
Australian authority fines and issues infringement notices to e-cigarette importers for containing banned ingredients.

The Therapeutic Goods Administration (TGA) in Australia had issued 38 infringement notices and imposed fines totalling AUD 588,840 against four importers of e-cigarettes for violating regulations.

 

The TGA laboratory has found prohibited substances in disposable e-cigarette samples from the brands IGET, GUNNPOD, and HQD, as per the therapeutic goods order for nicotine e-cigarette products (TGO 110) for 2021.

 

In response to the incident, 2FIRSTS promptly conducted an email interview with TGA. On June 21st, TGA Spokesperson replied to 2FIRSTS via email. TGA stated in their response that the disposable e-cigarette products IGET Bar, IGET Legend, GUNNPOD, and HQD were found to contain three prohibited ingredients: benzaldehyde, cinnamaldehyde, and ethylene glycol. According to a search on the TGA official website, (Standard for Nicotine Vaping Products) (TGO 110) Order 2021 specifies the three ingredients are prohibited in e-cigarette products.

 

The following response is from a spokesperson for the Australian Therapeutic Goods Administration.

 

Please attribute the following response to a spokesperson the Therapeutic Goods Administration.

 

1.Is it possible to announce the prohibited ingredients contained in IGET, GUNPOD and HQD branded vapes referenced in the media release?

 

Testing conducted by Therapeutic Goods Administration (TGA) Laboratories identified the IGET Bar and IGET Legend disposable pod devices contained benzaldehyde, cinnamaldehyde and ethylene glycol; Gunnpod disposable pod devices were found to contain benzaldehyde and ethylene glycol; and HQD disposable pod devices were found to contain benzaldehyde, cinnamaldehyde and ethylene glycol.

 

2.Will there be other punishments for the enterprises named, such as arrests? Will the enterprises that produce and manufacture these products also be punished?

 

Infringement notices are one of the compliance tools the TGA can use when we believe that a requirement of the Therapeutic Goods Act 1989 has been breached. If an entity does not pay the infringement notice, the TGA may take further action such as formal court action.

 

The Therapeutic Goods Act 1989 regulates the import, export, supply, manufacture and supply of therapeutic goods within Australia. As the products subject to the infringement notices are manufactured outside of Australia, the manufacturers are not subject to Australian laws.

 

3.Will TGA strengthen supervision in the future?

 

On 2 May 2023, the Minister for Health and Aged Care announced that the Australian Government is taking strong action to combat the supply of unlawful vaping products. The TGA is working closely with state and territory governments and the Australian Border Force to introduce a comprehensive range of reforms, including:

  • stopping the import of non-prescription vapes;
  • increasing the minimum quality standards for vapes including by restricting flavours, colours, and other ingredients;
  • requiring pharmaceutical-like packaging;
  • reducing nicotine concentrations and volumes;
  • banning all single use disposable vapes; and
  • ending vape sales in convenience stores and other retail settings.

 

Note: The previously mentioned "GUNPOD" should be corrected to "GUNNPOD," as stated by TGA in their email reply.

 

Reference(s):

 

Three TSG stores based in Sydney and Jaradat and Sabbagh Group Pty Ltd have been issued with infringement notices totalling $588,840.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board Backs New Vape Nicotine Exemption After Unanimously Opposing 2023 Proposal
Malaysia's Poisons Board has endorsed Health Minister Dzulkefly Ahmad's proposal to exempt liquid nicotine used in vaping products from the Poisons List, according to a November 2, 2026, report by CodeBlue. The Board unanimously opposed a similar proposal in 2023, but the government proceeded with the exemption. The Kuala Lumpur High Court invalidated the 2023 decision in May 2026, and the government withdrew its appeal in August. No new ministerial order has been published. The development raises questions about the interaction between Malaysia's two regulatory frameworks and the treatment of RM354.51 million in excise duties collected on e-cigarette and vape products between May 2023 and June 11, 2026.
Regulations
Nov.03